Central Admixture Pharmacy Services Inc recalls HYDROmorphone in 0.9% Sodium Chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Servic
Recalled October 11, 2023 · FDA recall D-0031-2024 · Central Admixture Pharmacy Services
Hazard
Lack of assurance of sterility: · FDA Class II
Units
2,664 30 mL syringes
Sold at
Nationwide in the USA
Description
Lack of assurance of sterility:
Product
HYDROmorphone in 0.9% Sodium Chloride, 30 mg/30 mL, (1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2012-1
Manufacturer(s)
Central Admixture Pharmacy Services Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →